Source: centralcharts

Press Release: Miromatrix : Shareholder Alert: Ademi LLP investigates whether Miromatrix Medical Inc. has obtained a Fair Price in its transaction with United Therapeutics

Shareholder Alert: Ademi LLP investigates whether Miromatrix Medical Inc. has obtained a Fair Price in its transaction with United Therapeutics PR Newswire

Read full article »

Miromatrix's Competitors | Miromatrix's News | Miromatrix's Financials

Followers on Owler

Annual Revenue

$100K-5.0M

Employees

25-100

CEO

Jeff Ross

CEO Approval Rating

90/100

Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.